New immune roadmaps help physicians detect cancer recurrence early and customize treatments to the body’s defenses, providing ...

Stem cell treatment targeting the bone beneath the knee reduced pain and improved movement more effectively than joint injections in osteoarthritis patients.

The designation applies to investigational therapies that target rare diseases affecting less than 200,000 people in the US.

ShardaCare Healthcity with GIFT to host thalassaemia awareness with a free HLA testing camp: Our Bureau, Bengaluru Tuesday, January 13, 2026, 12:45 Hrs [IST] ShardaCare Healthcity ...

NIGHT sweats, weight loss and feeling more tired than usual all sounded like classic menopause symptoms – or so Jessica ...

The FDA granted orphan drug designation to zavabresib, an investigational therapy for the treatment of myelofibrosis, a rare ...

SKY92 and next-generation sequencing (NGS) of bone marrow tumour cells into routine patient care for the first time in Ireland ...

January 21, 2026-- Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology th ...

Professor Idit Maya, a senior physician and manager of the Nephrogenetic Clinic and Genomic School for Physicians at Rabin ...

A growing movement of technically sophisticated patients are channeling their diagnoses into AI systems that address gaps ...

Your immune system is your body’s built-in defense network, working nonstop to protect you from bacteria, viruses, and other ...